These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34367495)

  • 1. Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis.
    Pfisterer N; Unger LW; Reiberger T
    World J Hepatol; 2021 Jul; 13(7):731-746. PubMed ID: 34367495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
    Gralnek IM; Camus Duboc M; Garcia-Pagan JC; Fuccio L; Karstensen JG; Hucl T; Jovanovic I; Awadie H; Hernandez-Gea V; Tantau M; Ebigbo A; Ibrahim M; Vlachogiannakos J; Burgmans MC; Rosasco R; Triantafyllou K
    Endoscopy; 2022 Nov; 54(11):1094-1120. PubMed ID: 36174643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding.
    Pfisterer N; Dexheimer C; Fuchs EM; Bucsics T; Schwabl P; Mandorfer M; Gessl I; Sandrieser L; Baumann L; Riedl F; Scheiner B; Pachofszky T; Dolak W; Schrutka-Kölbl C; Ferlitsch A; Schöniger-Hekele M; Peck-Radosavljevic M; Trauner M; Madl C; Reiberger T
    Aliment Pharmacol Ther; 2018 Apr; 47(7):966-979. PubMed ID: 29388229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
    Plaz Torres MC; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Roccarina D; Benmassaoud A; Iogna Prat L; Williams NR; Csenar M; Fritche D; Begum T; Arunan S; Tapp M; Milne EJ; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013122. PubMed ID: 33784794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension.
    Turco L; Reiberger T; Vitale G; La Mura V
    Liver Int; 2023 Jun; 43(6):1183-1194. PubMed ID: 36897563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Oesophageal Varices in Liver Cirrhosis.
    Sauerbruch T; Wong F
    Digestion; 2019; 99(4):261-266. PubMed ID: 30212817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of variceal haemorrhage in 2017.
    Brunner F; Berzigotti A; Bosch J
    Liver Int; 2017 Jan; 37 Suppl 1():104-115. PubMed ID: 28052623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
    Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of varices in patients with cirrhosis.
    O'Brien J; Triantos C; Burroughs AK
    Nat Rev Gastroenterol Hepatol; 2013 Jul; 10(7):402-12. PubMed ID: 23545523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding.
    Garbuzenko DV
    Curr Med Res Opin; 2016; 32(3):467-75. PubMed ID: 26804426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of band ligation for secondary prophylaxis of variceal bleeding.
    Aggeletopoulou I; Konstantakis C; Manolakopoulos S; Triantos C
    World J Gastroenterol; 2018 Jul; 24(26):2902-2914. PubMed ID: 30018485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prophylaxis for esophageal variceal bleeding.
    Albillos A; Tejedor M
    Clin Liver Dis; 2014 May; 18(2):359-70. PubMed ID: 24679500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding.
    Balcar L; Mandorfer M; Hernández-Gea V; Procopet B; Meyer EL; Giráldez Á; Amitrano L; Villanueva C; Thabut D; Samaniego LI; Silva-Junior G; Martinez J; Genescà J; Bureau C; Trebicka J; Herrera EL; Laleman W; Palazón Azorín JM; Alonso JC; Gluud LL; Ferreira CN; Cañete N; Rodríguez M; Ferlitsch A; Mundi JL; Grønbæk H; Hernandez Guerra MN; Sassatelli R; Dell'Era A; Senzolo M; Abraldes JG; Romero-Gómez M; Zipprich A; Casas M; Masnou H; Primignani M; Krag A; Nevens F; Calleja JL; Jansen C; Catalina MV; Albillos A; Rudler M; Tapias EA; Guardascione MA; Tantau M; Schwarzer R; Reiberger T; Laursen SB; Lopez-Gomez M; Cachero A; Ferrarese A; Ripoll C; La Mura V; Bosch J; García-Pagán JC;
    J Hepatol; 2024 Jan; 80(1):73-81. PubMed ID: 37852414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis.
    Gillespie SL; Hanrahan TP; Rockey DC; Majumdar A; Hayes PC
    Aliment Pharmacol Ther; 2023 Mar; 57(5):454-463. PubMed ID: 36691947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variceal and other portal hypertension related bleeding.
    Turon F; Casu S; Hernández-Gea V; Garcia-Pagán JC
    Best Pract Res Clin Gastroenterol; 2013 Oct; 27(5):649-64. PubMed ID: 24160925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
    Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011561. PubMed ID: 33522602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of covered stents for transjugular intrahepatic portosystemic stent shunt in patients with variceal bleeding and refractory ascites secondary to cirrhosis.
    Mattock R; Tripathi D; O'Neill F; Craig J; Tanner J; Patch D; Aithal G
    BMJ Open Gastroenterol; 2021 Aug; 8(1):. PubMed ID: 34429322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Therapies for Secondary Prophylaxis of Esophageal Variceal Bleeding in Cirrhosis: A Network Meta-analysis of Randomized Controlled Trials.
    Miao Z; Lu J; Yan J; Lu L; Ye B; Gu M
    Clin Ther; 2020 Jul; 42(7):1246-1275.e3. PubMed ID: 32624321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
    Strunk H; Marinova M
    Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker.
    Chen Y; Ma X; Zhang X; Luo J; An L; Zhang Y; Chang X; Dong Z; Zhang W; Kong H; Zhao J; Ding H; Liu F; Yang Y
    Hepatol Int; 2022 Dec; 16(6):1379-1389. PubMed ID: 36255564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.